login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
MERIT MEDICAL SYSTEMS INC (MMSI) Stock News
USA
- NASDAQ:MMSI -
US5898891040
-
Common Stock
88.33
USD
+0.78 (+0.89%)
Last: 11/10/2025, 8:11:38 PM
88.33
USD
0 (0%)
After Hours:
11/10/2025, 8:11:38 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MMSI Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Zacks Investment Research
- Mentions:
CNMD
CNMD or MMSI: Which Is the Better Value Stock Right Now?
6 days ago - By: Merit Medical Systems, Inc.
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
12 days ago - By: Benzinga
- Mentions:
IR
CDP
ENTG
BUD
...
Earnings Scheduled For October 30, 2025
12 days ago - By: Benzinga
Exploring Merit Medical Systems's Earnings Expectations
a month ago - By: Zacks Investment Research
MMSI vs. SAUHY: Which Stock Is the Better Value Option?
8 days ago - By: Merit Medical Systems, Inc.
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
10 days ago - By: Zacks Investment Research
- Mentions:
BSX
ISRG
GEHC
Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand
2 months ago - By: Zacks Investment Research
- Mentions:
BDX
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
3 months ago - By: Zacks Investment Research
- Mentions:
COO
COO vs. MMSI: Which Stock Is the Better Value Option?
11 days ago - By: Merit Medical Systems, Inc.
Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance
17 days ago - By: Zacks Investment Research
- Mentions:
MASI
FMS
WST
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
18 days ago - By: Zacks Investment Research
- Mentions:
MASI
WST
OPK
Here's Why You Should Add OPKO Health Stock to Your Portfolio
19 days ago - By: Zacks Investment Research
- Mentions:
BSX
MASI
WST
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
25 days ago - By: Zacks Investment Research
- Mentions:
MASI
WST
AVTR
Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing
a month ago - By: PENTAX Medical
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement
a month ago - By: Merit Medical Systems, Inc.
Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
a month ago - By: Zacks Investment Research
- Mentions:
MASI
WST
INSP
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials
a month ago - By: Merit Medical Systems, Inc.
Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
a month ago - By: Zacks Investment Research
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term
a month ago - By: Merit Medical Systems, Inc.
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
a month ago - By: Zacks Investment Research
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
2 months ago - By: Zacks Investment Research
- Mentions:
WST
MEDP
NVST
MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care
2 months ago - By: Merit Medical Systems, Inc.
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis
Please enable JavaScript to continue using this application.